54/120
2.3 / 5 stars
All 120 Win/Lose results shown below
CI Roast Me summary
Cigna Group (CI). Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Win; Revenue growth Lose; EPS growth Win.
- 2025-Q4: Total return Lose; Revenue growth Win; EPS growth Win.
- 2025-Q3: Total return Lose; Revenue growth Win; EPS growth Win.
Trailing 1 year (4 quarters): 6 wins, 6 lossesLast fetched: 25 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseCI / S&P 3.95% / 15.20% |
LoseCI / S&P 7.77% / 15.00% |
LoseCI / S&P 32.48% / 50.40% |
| 2026-Q12/3 |
WinCI / S&P -2.55% / -4.33% |
LoseCI / S&P 8.82% / 11.30% |
WinCI / S&P 31.17% / 27.70% |
| 2025-Q42/3 |
LoseCI / S&P -3.98% / 2.65% |
WinCI / S&P 11.24% / 9.00% |
WinCI / S&P 83.00% / 13.40% |
| 2025-Q32/3 |
LoseCI / S&P -12.36% / 8.12% |
WinCI / S&P 15.26% / 4.61% |
WinCI / S&P 113.10% / 13.45% |
| 2025-Q22/3 |
LoseCI / S&P 0.96% / 10.94% |
WinCI / S&P 20.23% / 4.83% |
WinCI / S&P 43.55% / 10.63% |
| 2025-Q13/3 |
WinCI / S&P 19.73% / -4.27% |
WinCI / S&P 23.96% / 4.98% |
WinCI / S&P 47.66% / 10.57% |
| 2024-Q41/3 |
LoseCI / S&P -19.96% / 2.41% |
WinCI / S&P 26.56% / 5.25% |
LoseCI / S&P -30.30% / 6.15% |
| 2024-Q31/3 |
LoseCI / S&P 5.20% / 5.89% |
WinCI / S&P 22.48% / 5.89% |
LoseCI / S&P -40.56% / 6.11% |
| 2024-Q21/3 |
LoseCI / S&P -8.61% / 4.28% |
WinCI / S&P 17.09% / 5.38% |
LoseCI / S&P -42.39% / 5.12% |
| 2024-Q12/3 |
WinCI / S&P 21.79% / 10.56% |
WinCI / S&P 12.55% / 5.71% |
LoseCI / S&P -44.72% / 5.59% |
| 2023-Q41/3 |
LoseCI / S&P 5.17% / 11.69% |
WinCI / S&P 8.17% / 6.81% |
LoseCI / S&P -18.78% / 7.78% |
| 2023-Q31/3 |
WinCI / S&P 2.40% / -3.27% |
LoseCI / S&P 5.24% / 7.52% |
LoseCI / S&P -15.08% / -5.03% |
| 2023-Q22/3 |
WinCI / S&P 10.33% / 8.74% |
LoseCI / S&P 3.73% / 9.50% |
WinCI / S&P 31.04% / -8.57% |
| 2023-Q11/3 |
LoseCI / S&P -22.55% / 7.50% |
LoseCI / S&P 3.35% / 10.77% |
WinCI / S&P 36.03% / -15.69% |
| 2022-Q42/3 |
WinCI / S&P 19.82% / 7.56% |
LoseCI / S&P 3.70% / 11.88% |
WinCI / S&P 35.94% / -17.99% |
| 2022-Q31/3 |
WinCI / S&P 5.71% / -4.88% |
LoseCI / S&P 6.08% / 13.47% |
LoseCI / S&P -11.12% / -1.41% |
| 2022-Q21/3 |
WinCI / S&P 10.46% / -16.10% |
LoseCI / S&P 7.60% / 13.71% |
LoseCI / S&P -25.54% / 11.04% |
| 2022-Q11/3 |
WinCI / S&P 4.84% / -4.60% |
LoseCI / S&P 8.72% / 15.97% |
LoseCI / S&P -29.86% / 42.23% |
| 2021-Q41/3 |
WinCI / S&P 15.30% / 11.03% |
LoseCI / S&P 8.52% / 15.00% |
LoseCI / S&P -31.40% / 96.40% |
| 2021-Q30/3 |
LoseCI / S&P -15.18% / 0.58% |
LoseCI / S&P 8.39% / 10.77% |
LoseCI / S&P 65.73% / 69.42% |
| 2021-Q22/3 |
LoseCI / S&P -1.54% / 8.55% |
WinCI / S&P 7.92% / 6.58% |
WinCI / S&P 60.95% / 51.81% |
| 2021-Q13/3 |
WinCI / S&P 16.62% / 6.17% |
WinCI / S&P 5.72% / -1.06% |
WinCI / S&P 77.36% / 7.39% |
| 2020-Q43/3 |
WinCI / S&P 22.89% / 12.15% |
WinCI / S&P 4.45% / -3.72% |
WinCI / S&P 70.83% / -33.42% |
| 2020-Q32/3 |
LoseCI / S&P -9.72% / 8.93% |
WinCI / S&P 21.07% / -2.04% |
WinCI / S&P 27.07% / -27.10% |
| 2020-Q22/3 |
LoseCI / S&P 5.91% / 20.54% |
WinCI / S&P 50.73% / -0.46% |
WinCI / S&P 30.19% / -27.11% |
| 2020-Q13/3 |
WinCI / S&P -13.34% / -19.60% |
WinCI / S&P 104.95% / 3.47% |
WinCI / S&P 25.41% / -14.75% |
| 2019-Q43/3 |
WinCI / S&P 34.72% / 9.07% |
WinCI / S&P 215.65% / 5.36% |
WinCI / S&P 27.51% / 2.99% |
| 2019-Q30/3 |
LoseCI / S&P -3.66% / 1.70% |
LoseCI / S&P CI unavailable / 5.02% |
LoseCI / S&P CI unavailable / 0.21% |
| 2019-Q20/3 |
LoseCI / S&P -2.03% / 4.30% |
LoseCI / S&P CI unavailable / 6.64% |
LoseCI / S&P CI unavailable / 8.65% |
| 2019-Q10/3 |
LoseCI / S&P -15.30% / 13.65% |
LoseCI / S&P CI unavailable / 8.12% |
LoseCI / S&P CI unavailable / 14.29% |
| 2018-Q43/3 |
WinCI / S&P -8.80% / -13.52% |
WinCI / S&P 16.37% / 9.05% |
WinCI / S&P 20.18% / 18.23% |
| 2018-Q31/3 |
WinCI / S&P 22.54% / 7.71% |
LoseCI / S&P CI unavailable / 10.21% |
LoseCI / S&P CI unavailable / 19.06% |
| 2018-Q20/3 |
LoseCI / S&P 1.32% / 3.43% |
LoseCI / S&P CI unavailable / 9.03% |
LoseCI / S&P CI unavailable / 14.46% |
| 2018-Q10/3 |
LoseCI / S&P -17.39% / -0.76% |
LoseCI / S&P CI unavailable / 7.68% |
LoseCI / S&P CI unavailable / 12.46% |
| 2017-Q42/3 |
WinCI / S&P 8.64% / 6.64% |
LoseCI / S&P 4.94% / 7.03% |
WinCI / S&P 21.97% / 13.82% |
| 2017-Q31/3 |
WinCI / S&P 11.68% / 4.48% |
LoseCI / S&P CI unavailable / 5.68% |
LoseCI / S&P CI unavailable / 17.57% |
| 2017-Q21/3 |
WinCI / S&P 14.27% / 3.09% |
LoseCI / S&P CI unavailable / 4.83% |
LoseCI / S&P CI unavailable / 17.74% |
| 2017-Q11/3 |
WinCI / S&P 9.85% / 6.07% |
LoseCI / S&P CI unavailable / 3.67% |
LoseCI / S&P CI unavailable / 13.32% |
| 2016-Q40/3 |
LoseCI / S&P 2.36% / 3.82% |
LoseCI / S&P CI unavailable / 2.09% |
LoseCI / S&P CI unavailable / 7.05% |
| 2016-Q30/3 |
LoseCI / S&P 1.82% / 3.85% |
LoseCI / S&P CI unavailable / 0.20% |
LoseCI / S&P CI unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-28
| Metric | CI total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -5.19% | 20.78% |
| Annualized return | -5.19% | 20.78% |
5Y · 2021-09-01 to 2026-08-28
| Metric | CI total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 44.99% | 83.14% |
| Annualized return | 7.71% | 12.86% |
10Y · 2016-09-01 to 2026-08-28
| Metric | CI total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 141.94% | 319.30% |
| Annualized return | 9.24% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-25.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health, Inc. (ELV) | United States | $86.364B | 16.90 |
| HUMANA INC (HUM) | United States | $45.651B | 18.44 |
| CENTENE CORP (CNC) | United States | $30.588B | -6.22 |
| MOLINA HEALTHCARE, INC. (MOH) | United States | $10.091B | -1,697.50 |
| Alignment Healthcare, Inc. (ALHC) | United States | $1.593B | 121.28 |
| TRUPANION, INC. (TRUP) | United States | $0.984B | |
| UNITEDHEALTH GROUP INC (UNH) | United States | $336.652B | 26.62 |